N-acetylcysteine for the treatment of COVID-19 among hospitalized patients

被引：16
|
作者：
Avdeev, Sergey N. [1 ]
Gaynitdinova, Viliya V. [1 ]
Merzhoeva, Zamira M. [1 ]
Berikkhanov, Zelimkhan G. -M. [1 ]
机构：
[1] Sechenov Univ, IM Sechenov First Moscow State Med Univ, Dept Pulmonol, Moscow, Russia
来源：
JOURNAL OF INFECTION | 2022年 / 84卷 / 01期
关键词：
D O I：
10.1016/j.jinf.2021.07.003
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：99 / 101
页数：3
相关论文
共 50 条
  • [21] N-Acetylcysteine and Other Sulfur-Donors as a Preventative and Adjunct Therapy for COVID-19
    du Preez, Heidi N.
    Aldous, Colleen
    Kruger, Hendrik G.
    Johnson, Lin
    [J]. ADVANCES IN PHARMACOLOGICAL AND PHARMACEUTICAL SCIENCES, 2022, 2022
  • [22] COVID-19 treatment approaches among hospitalized patients in a national healthcare system
    Liao, Jennifer X.
    Lopes, Vrishali V.
    LaPlante, Kerry L.
    Caffrey, Aisling R.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 188 - 188
  • [23] PLEURAL PATHOLOGY AMONG HOSPITALIZED PATIENTS WITH COVID-19
    Sen, Aritra
    Tabba, Maher
    [J]. CHEST, 2021, 160 (04) : 1367A - 1367A
  • [24] The efficacy of N-Acetylcysteine in severe COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial
    Arash Rahimi
    Hamid Reza Samimagham
    Mehdi Hassani Azad
    Dariush Hooshyar
    Mohsen Arabi
    Mitra KazemiJahromi
    [J]. Trials, 22
  • [25] The efficacy of N-Acetylcysteine in severe COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial
    Rahimi, Arash
    Samimagham, Hamid Reza
    Azad, Mehdi Hassani
    Hooshyar, Dariush
    Arabi, Mohsen
    KazemiJahromi, Mitra
    [J]. TRIALS, 2021, 22 (01)
  • [26] Severe Glutathione Deficiency, Oxidative Stress and Oxidant Damage in Adults Hospitalized with COVID-19: Implications for GlyNAC (Glycine and N-Acetylcysteine) Supplementation
    Kumar, Premranjan
    Osahon, Ob
    Vides, David B.
    Hanania, Nicola
    Minard, Charles G.
    Sekhar, Rajagopal V.
    [J]. ANTIOXIDANTS, 2022, 11 (01)
  • [27] EVALUATION OF TREATMENT APPROACHES FOR HOSPITALIZED COVID-19 PATIENTS
    Kilcoyne, A.
    Jordan, E.
    Durrant, C.
    Chappell, D.
    Ahmed, O.
    [J]. THORAX, 2021, 76 : A35 - A36
  • [28] Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
    Luís Coelho
    Fatima Falcão
    Pedro Póvoa
    Erica Viegas
    Antonio Pais Martins
    Eduarda Carmo
    Candida Fonseca
    Luis Campos
    Kamal Mansinho
    Inês Carmo
    Joana Soares
    Mariana Solano
    Dina Mendes
    Ana Cláudia Miranda
    Antonio Carvalho
    Ana Mirco
    Helena Farinha
    Isabel Aldir
    José Correia
    [J]. Scientific Reports, 13
  • [29] Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19
    Somersan-Karakaya, Selin
    Mylonakis, Eleftherios
    Menon, Vidya P.
    Wells, Jason C.
    Ali, Shazia
    Sivapalasingam, Sumathi
    Sun, Yiping
    Bhore, Rafia
    Mei, Jingning
    Miller, Jutta
    Cupelli, Lisa
    Forleo-Neto, Eduardo
    Hooper, Andrea T.
    Hamilton, Jennifer D.
    Pan, Cynthia
    Pham, Viet
    Zhao, Yuming
    Hosain, Romana
    Mahmood, Adnan
    Davis, John D.
    Turner, Kenneth C.
    Kim, Yunji
    Cook, Amanda
    Kowal, Bari
    Soo, Yuhwen
    DiCioccio, A. Thomas
    Geba, Gregory P.
    Stahl, Neil
    Lipsich, Leah
    Braunstein, Ned
    Herman, Gary A.
    Yancopoulos, George D.
    Weinreich, David M.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2022, 227 (01): : 23 - 34
  • [30] CORTICOSTEROID TREATMENT RESPONSE IN HOSPITALIZED COVID-19 PATIENTS
    Williams, Stephanie
    Lattanzio, Natalia
    Walo, Richard
    Hamad, Karen
    Wiese-Rometsch, Wilhelmine
    Seaman, Joseph
    [J]. CRITICAL CARE MEDICINE, 2022, 50 (01) : 87 - 87
12345